CO135 Hospitalization and Exacerbation Estimates of Efgartigimod Vs. Conventional Therapy in Generalized Myasthenia Gravis Patients: A Post-Hoc Analysis of the Phase 3 ADAPT Study
Abstract
Authors
C Qi S Dewilde D Gelinas E Brauer G Phillips